EnteroMedics (ETRM) is a Buy Ahead of June Panel - Northland Capital Markets
Tweet Send to a Friend
Northland Capital Markets analyst Suraj Kalia reiterated an Outperform rating and $7 price target on EnteroMedics (NASDAQ: ETRM) saying they ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
